COVID-19 Impact on Global Polycystic Kidney Disease Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 93 pages | ID: C78D3AE80F9FEN
QYResearch

Abstracts

This report focuses on the global Polycystic Kidney Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Polycystic Kidney Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Angion Biomedica Corp
• Aptevo Therapeutics Inc
• Celgene Corp
• Conatus Pharmaceuticals Inc
• DiscoveryBiomed Inc
• Endocyte Inc
• IC-MedTech Inc
• Ipsen SA
• Kadmon Corp LLC
• Madrigal Pharmaceuticals Inc.
• ManRos Therapeutics
• Metabolic Solutions Development Company LLC
• Mironid Ltd

Market segment by Type, the product can be split into

• ANG-3070
• CIM-2
• CR-8
• Others

Market segment by Application, split into

• Clinic
• Research Center
• Hospital

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Polycystic Kidney Disease Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Polycystic Kidney Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Polycystic Kidney Disease Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Polycystic Kidney Disease Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Polycystic Kidney Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 ANG-3070
  1.4.3 CIM-2
  1.4.4 CR-8
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Polycystic Kidney Disease Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Clinic
  1.5.3 Research Center
  1.5.4 Hospital
1.6 Coronavirus Disease 2019 (Covid-19): Polycystic Kidney Disease Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Polycystic Kidney Disease Treatment Industry
    1.6.1.1 Polycystic Kidney Disease Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Polycystic Kidney Disease Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Polycystic Kidney Disease Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Polycystic Kidney Disease Treatment Market Perspective (2015-2026)
2.2 Polycystic Kidney Disease Treatment Growth Trends by Regions
  2.2.1 Polycystic Kidney Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Polycystic Kidney Disease Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Polycystic Kidney Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Polycystic Kidney Disease Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Polycystic Kidney Disease Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Polycystic Kidney Disease Treatment Players by Market Size
  3.1.1 Global Top Polycystic Kidney Disease Treatment Players by Revenue (2015-2020)
  3.1.2 Global Polycystic Kidney Disease Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Polycystic Kidney Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Polycystic Kidney Disease Treatment Market Concentration Ratio
  3.2.1 Global Polycystic Kidney Disease Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Polycystic Kidney Disease Treatment Revenue in 2019
3.3 Polycystic Kidney Disease Treatment Key Players Head office and Area Served
3.4 Key Players Polycystic Kidney Disease Treatment Product Solution and Service
3.5 Date of Enter into Polycystic Kidney Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Polycystic Kidney Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Polycystic Kidney Disease Treatment Forecasted Market Size by Type (2021-2026)

5 POLYCYSTIC KIDNEY DISEASE TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Polycystic Kidney Disease Treatment Market Size by Application (2015-2020)
5.2 Global Polycystic Kidney Disease Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Polycystic Kidney Disease Treatment Market Size (2015-2020)
6.2 Polycystic Kidney Disease Treatment Key Players in North America (2019-2020)
6.3 North America Polycystic Kidney Disease Treatment Market Size by Type (2015-2020)
6.4 North America Polycystic Kidney Disease Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Polycystic Kidney Disease Treatment Market Size (2015-2020)
7.2 Polycystic Kidney Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Polycystic Kidney Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Polycystic Kidney Disease Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Polycystic Kidney Disease Treatment Market Size (2015-2020)
8.2 Polycystic Kidney Disease Treatment Key Players in China (2019-2020)
8.3 China Polycystic Kidney Disease Treatment Market Size by Type (2015-2020)
8.4 China Polycystic Kidney Disease Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Polycystic Kidney Disease Treatment Market Size (2015-2020)
9.2 Polycystic Kidney Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Polycystic Kidney Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Polycystic Kidney Disease Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Polycystic Kidney Disease Treatment Market Size (2015-2020)
10.2 Polycystic Kidney Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Polycystic Kidney Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Polycystic Kidney Disease Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Polycystic Kidney Disease Treatment Market Size (2015-2020)
11.2 Polycystic Kidney Disease Treatment Key Players in India (2019-2020)
11.3 India Polycystic Kidney Disease Treatment Market Size by Type (2015-2020)
11.4 India Polycystic Kidney Disease Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Polycystic Kidney Disease Treatment Market Size (2015-2020)
12.2 Polycystic Kidney Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Polycystic Kidney Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Polycystic Kidney Disease Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Angion Biomedica Corp
  13.1.1 Angion Biomedica Corp Company Details
  13.1.2 Angion Biomedica Corp Business Overview and Its Total Revenue
  13.1.3 Angion Biomedica Corp Polycystic Kidney Disease Treatment Introduction
  13.1.4 Angion Biomedica Corp Revenue in Polycystic Kidney Disease Treatment Business (2015-2020))
  13.1.5 Angion Biomedica Corp Recent Development
13.2 Aptevo Therapeutics Inc
  13.2.1 Aptevo Therapeutics Inc Company Details
  13.2.2 Aptevo Therapeutics Inc Business Overview and Its Total Revenue
  13.2.3 Aptevo Therapeutics Inc Polycystic Kidney Disease Treatment Introduction
  13.2.4 Aptevo Therapeutics Inc Revenue in Polycystic Kidney Disease Treatment Business (2015-2020)
  13.2.5 Aptevo Therapeutics Inc Recent Development
13.3 Celgene Corp
  13.3.1 Celgene Corp Company Details
  13.3.2 Celgene Corp Business Overview and Its Total Revenue
  13.3.3 Celgene Corp Polycystic Kidney Disease Treatment Introduction
  13.3.4 Celgene Corp Revenue in Polycystic Kidney Disease Treatment Business (2015-2020)
  13.3.5 Celgene Corp Recent Development
13.4 Conatus Pharmaceuticals Inc
  13.4.1 Conatus Pharmaceuticals Inc Company Details
  13.4.2 Conatus Pharmaceuticals Inc Business Overview and Its Total Revenue
  13.4.3 Conatus Pharmaceuticals Inc Polycystic Kidney Disease Treatment Introduction
  13.4.4 Conatus Pharmaceuticals Inc Revenue in Polycystic Kidney Disease Treatment Business (2015-2020)
  13.4.5 Conatus Pharmaceuticals Inc Recent Development
13.5 DiscoveryBiomed Inc
  13.5.1 DiscoveryBiomed Inc Company Details
  13.5.2 DiscoveryBiomed Inc Business Overview and Its Total Revenue
  13.5.3 DiscoveryBiomed Inc Polycystic Kidney Disease Treatment Introduction
  13.5.4 DiscoveryBiomed Inc Revenue in Polycystic Kidney Disease Treatment Business (2015-2020)
  13.5.5 DiscoveryBiomed Inc Recent Development
13.6 Endocyte Inc
  13.6.1 Endocyte Inc Company Details
  13.6.2 Endocyte Inc Business Overview and Its Total Revenue
  13.6.3 Endocyte Inc Polycystic Kidney Disease Treatment Introduction
  13.6.4 Endocyte Inc Revenue in Polycystic Kidney Disease Treatment Business (2015-2020)
  13.6.5 Endocyte Inc Recent Development
13.7 IC-MedTech Inc
  13.7.1 IC-MedTech Inc Company Details
  13.7.2 IC-MedTech Inc Business Overview and Its Total Revenue
  13.7.3 IC-MedTech Inc Polycystic Kidney Disease Treatment Introduction
  13.7.4 IC-MedTech Inc Revenue in Polycystic Kidney Disease Treatment Business (2015-2020)
  13.7.5 IC-MedTech Inc Recent Development
13.8 Ipsen SA
  13.8.1 Ipsen SA Company Details
  13.8.2 Ipsen SA Business Overview and Its Total Revenue
  13.8.3 Ipsen SA Polycystic Kidney Disease Treatment Introduction
  13.8.4 Ipsen SA Revenue in Polycystic Kidney Disease Treatment Business (2015-2020)
  13.8.5 Ipsen SA Recent Development
13.9 Kadmon Corp LLC
  13.9.1 Kadmon Corp LLC Company Details
  13.9.2 Kadmon Corp LLC Business Overview and Its Total Revenue
  13.9.3 Kadmon Corp LLC Polycystic Kidney Disease Treatment Introduction
  13.9.4 Kadmon Corp LLC Revenue in Polycystic Kidney Disease Treatment Business (2015-2020)
  13.9.5 Kadmon Corp LLC Recent Development
13.10 Madrigal Pharmaceuticals Inc.
  13.10.1 Madrigal Pharmaceuticals Inc. Company Details
  13.10.2 Madrigal Pharmaceuticals Inc. Business Overview and Its Total Revenue
  13.10.3 Madrigal Pharmaceuticals Inc. Polycystic Kidney Disease Treatment Introduction
  13.10.4 Madrigal Pharmaceuticals Inc. Revenue in Polycystic Kidney Disease Treatment Business (2015-2020)
  13.10.5 Madrigal Pharmaceuticals Inc. Recent Development
13.11 ManRos Therapeutics
  10.11.1 ManRos Therapeutics Company Details
  10.11.2 ManRos Therapeutics Business Overview and Its Total Revenue
  10.11.3 ManRos Therapeutics Polycystic Kidney Disease Treatment Introduction
  10.11.4 ManRos Therapeutics Revenue in Polycystic Kidney Disease Treatment Business (2015-2020)
  10.11.5 ManRos Therapeutics Recent Development
13.12 Metabolic Solutions Development Company LLC
  10.12.1 Metabolic Solutions Development Company LLC Company Details
  10.12.2 Metabolic Solutions Development Company LLC Business Overview and Its Total Revenue
  10.12.3 Metabolic Solutions Development Company LLC Polycystic Kidney Disease Treatment Introduction
  10.12.4 Metabolic Solutions Development Company LLC Revenue in Polycystic Kidney Disease Treatment Business (2015-2020)
  10.12.5 Metabolic Solutions Development Company LLC Recent Development
13.13 Mironid Ltd
  10.13.1 Mironid Ltd Company Details
  10.13.2 Mironid Ltd Business Overview and Its Total Revenue
  10.13.3 Mironid Ltd Polycystic Kidney Disease Treatment Introduction
  10.13.4 Mironid Ltd Revenue in Polycystic Kidney Disease Treatment Business (2015-2020)
  10.13.5 Mironid Ltd Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Polycystic Kidney Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Polycystic Kidney Disease Treatment Revenue
Table 3. Ranking of Global Top Polycystic Kidney Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Polycystic Kidney Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of ANG-3070
Table 6. Key Players of CIM-2
Table 7. Key Players of CR-8
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Polycystic Kidney Disease Treatment Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Polycystic Kidney Disease Treatment Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Polycystic Kidney Disease Treatment Players to Combat Covid-19 Impact
Table 14. Global Polycystic Kidney Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Polycystic Kidney Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Polycystic Kidney Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Polycystic Kidney Disease Treatment Market Share by Regions (2015-2020)
Table 18. Global Polycystic Kidney Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Polycystic Kidney Disease Treatment Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Polycystic Kidney Disease Treatment Market Growth Strategy
Table 24. Main Points Interviewed from Key Polycystic Kidney Disease Treatment Players
Table 25. Global Polycystic Kidney Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 26. Global Polycystic Kidney Disease Treatment Market Share by Players (2015-2020)
Table 27. Global Top Polycystic Kidney Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polycystic Kidney Disease Treatment as of 2019)
Table 28. Global Polycystic Kidney Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Polycystic Kidney Disease Treatment Product Solution and Service
Table 31. Date of Enter into Polycystic Kidney Disease Treatment Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Polycystic Kidney Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 34. Global Polycystic Kidney Disease Treatment Market Size Share by Type (2015-2020)
Table 35. Global Polycystic Kidney Disease Treatment Revenue Market Share by Type (2021-2026)
Table 36. Global Polycystic Kidney Disease Treatment Market Size Share by Application (2015-2020)
Table 37. Global Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. Global Polycystic Kidney Disease Treatment Market Size Share by Application (2021-2026)
Table 39. North America Key Players Polycystic Kidney Disease Treatment Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Polycystic Kidney Disease Treatment Market Share (2019-2020)
Table 41. North America Polycystic Kidney Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. North America Polycystic Kidney Disease Treatment Market Share by Type (2015-2020)
Table 43. North America Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. North America Polycystic Kidney Disease Treatment Market Share by Application (2015-2020)
Table 45. Europe Key Players Polycystic Kidney Disease Treatment Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Polycystic Kidney Disease Treatment Market Share (2019-2020)
Table 47. Europe Polycystic Kidney Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Polycystic Kidney Disease Treatment Market Share by Type (2015-2020)
Table 49. Europe Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Polycystic Kidney Disease Treatment Market Share by Application (2015-2020)
Table 51. China Key Players Polycystic Kidney Disease Treatment Revenue (2019-2020) (Million US$)
Table 52. China Key Players Polycystic Kidney Disease Treatment Market Share (2019-2020)
Table 53. China Polycystic Kidney Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. China Polycystic Kidney Disease Treatment Market Share by Type (2015-2020)
Table 55. China Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. China Polycystic Kidney Disease Treatment Market Share by Application (2015-2020)
Table 57. Japan Key Players Polycystic Kidney Disease Treatment Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Polycystic Kidney Disease Treatment Market Share (2019-2020)
Table 59. Japan Polycystic Kidney Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Polycystic Kidney Disease Treatment Market Share by Type (2015-2020)
Table 61. Japan Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Polycystic Kidney Disease Treatment Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Polycystic Kidney Disease Treatment Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Polycystic Kidney Disease Treatment Market Share (2019-2020)
Table 65. Southeast Asia Polycystic Kidney Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Polycystic Kidney Disease Treatment Market Share by Type (2015-2020)
Table 67. Southeast Asia Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Polycystic Kidney Disease Treatment Market Share by Application (2015-2020)
Table 69. India Key Players Polycystic Kidney Disease Treatment Revenue (2019-2020) (Million US$)
Table 70. India Key Players Polycystic Kidney Disease Treatment Market Share (2019-2020)
Table 71. India Polycystic Kidney Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. India Polycystic Kidney Disease Treatment Market Share by Type (2015-2020)
Table 73. India Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. India Polycystic Kidney Disease Treatment Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Polycystic Kidney Disease Treatment Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Polycystic Kidney Disease Treatment Market Share (2019-2020)
Table 77. Central & South America Polycystic Kidney Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Polycystic Kidney Disease Treatment Market Share by Type (2015-2020)
Table 79. Central & South America Polycystic Kidney Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Polycystic Kidney Disease Treatment Market Share by Application (2015-2020)
Table 81. Angion Biomedica Corp Company Details
Table 82. Angion Biomedica Corp Business Overview
Table 83. Angion Biomedica Corp Product
Table 84. Angion Biomedica Corp Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$)
Table 85. Angion Biomedica Corp Recent Development
Table 86. Aptevo Therapeutics Inc Company Details
Table 87. Aptevo Therapeutics Inc Business Overview
Table 88. Aptevo Therapeutics Inc Product
Table 89. Aptevo Therapeutics Inc Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$)
Table 90. Aptevo Therapeutics Inc Recent Development
Table 91. Celgene Corp Company Details
Table 92. Celgene Corp Business Overview
Table 93. Celgene Corp Product
Table 94. Celgene Corp Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$)
Table 95. Celgene Corp Recent Development
Table 96. Conatus Pharmaceuticals Inc Company Details
Table 97. Conatus Pharmaceuticals Inc Business Overview
Table 98. Conatus Pharmaceuticals Inc Product
Table 99. Conatus Pharmaceuticals Inc Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$)
Table 100. Conatus Pharmaceuticals Inc Recent Development
Table 101. DiscoveryBiomed Inc Company Details
Table 102. DiscoveryBiomed Inc Business Overview
Table 103. DiscoveryBiomed Inc Product
Table 104. DiscoveryBiomed Inc Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$)
Table 105. DiscoveryBiomed Inc Recent Development
Table 106. Endocyte Inc Company Details
Table 107. Endocyte Inc Business Overview
Table 108. Endocyte Inc Product
Table 109. Endocyte Inc Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$)
Table 110. Endocyte Inc Recent Development
Table 111. IC-MedTech Inc Company Details
Table 112. IC-MedTech Inc Business Overview
Table 113. IC-MedTech Inc Product
Table 114. IC-MedTech Inc Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$)
Table 115. IC-MedTech Inc Recent Development
Table 116. Ipsen SA Business Overview
Table 117. Ipsen SA Product
Table 118. Ipsen SA Company Details
Table 119. Ipsen SA Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$)
Table 120. Ipsen SA Recent Development
Table 121. Kadmon Corp LLC Company Details
Table 122. Kadmon Corp LLC Business Overview
Table 123. Kadmon Corp LLC Product
Table 124. Kadmon Corp LLC Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$)
Table 125. Kadmon Corp LLC Recent Development
Table 126. Madrigal Pharmaceuticals Inc. Company Details
Table 127. Madrigal Pharmaceuticals Inc. Business Overview
Table 128. Madrigal Pharmaceuticals Inc. Product
Table 129. Madrigal Pharmaceuticals Inc. Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$)
Table 130. Madrigal Pharmaceuticals Inc. Recent Development
Table 131. ManRos Therapeutics Company Details
Table 132. ManRos Therapeutics Business Overview
Table 133. ManRos Therapeutics Product
Table 134. ManRos Therapeutics Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$)
Table 135. ManRos Therapeutics Recent Development
Table 136. Metabolic Solutions Development Company LLC Company Details
Table 137. Metabolic Solutions Development Company LLC Business Overview
Table 138. Metabolic Solutions Development Company LLC Product
Table 139. Metabolic Solutions Development Company LLC Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$)
Table 140. Metabolic Solutions Development Company LLC Recent Development
Table 141. Mironid Ltd Company Details
Table 142. Mironid Ltd Business Overview
Table 143. Mironid Ltd Product
Table 144. Mironid Ltd Revenue in Polycystic Kidney Disease Treatment Business (2015-2020) (Million US$)
Table 145. Mironid Ltd Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Polycystic Kidney Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. ANG-3070 Features
Figure 3. CIM-2 Features
Figure 4. CR-8 Features
Figure 5. Others Features
Figure 6. Global Polycystic Kidney Disease Treatment Market Share by Application: 2020 VS 2026
Figure 7. Clinic Case Studies
Figure 8. Research Center Case Studies
Figure 9. Hospital Case Studies
Figure 10. Polycystic Kidney Disease Treatment Report Years Considered
Figure 11. Global Polycystic Kidney Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Polycystic Kidney Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Polycystic Kidney Disease Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Polycystic Kidney Disease Treatment Market Share by Players in 2019
Figure 16. Global Top Polycystic Kidney Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polycystic Kidney Disease Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Polycystic Kidney Disease Treatment Revenue in 2019
Figure 18. North America Polycystic Kidney Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Polycystic Kidney Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Polycystic Kidney Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Polycystic Kidney Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Polycystic Kidney Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Polycystic Kidney Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Polycystic Kidney Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Angion Biomedica Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Angion Biomedica Corp Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020)
Figure 27. Aptevo Therapeutics Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Aptevo Therapeutics Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020)
Figure 29. Celgene Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Celgene Corp Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020)
Figure 31. Conatus Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Conatus Pharmaceuticals Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020)
Figure 33. DiscoveryBiomed Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. DiscoveryBiomed Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020)
Figure 35. Endocyte Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Endocyte Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020)
Figure 37. IC-MedTech Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. IC-MedTech Inc Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020)
Figure 39. Ipsen SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Ipsen SA Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020)
Figure 41. Kadmon Corp LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Kadmon Corp LLC Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020)
Figure 43. Madrigal Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Madrigal Pharmaceuticals Inc. Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020)
Figure 45. ManRos Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. ManRos Therapeutics Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020)
Figure 47. Metabolic Solutions Development Company LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Metabolic Solutions Development Company LLC Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020)
Figure 49. Mironid Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Mironid Ltd Revenue Growth Rate in Polycystic Kidney Disease Treatment Business (2015-2020)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed